iRhythm Holdings (IRTC) Cash from Operations (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | iRhythm Holdings | 3.55 Bn | 3.00 Bn | 141.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -199.85% |
| Dec 31, 2025 | -24.86% |
| Sep 30, 2025 | 26.12% |
| Jun 30, 2025 | 450.51% |
| Mar 31, 2025 | -141.03% |
| Dec 31, 2024 | -21.01% |
| Sep 30, 2024 | 105.63% |
| Jun 30, 2024 | 122.76% |
| Mar 31, 2024 | -225.75% |
| Dec 31, 2023 | -1,435.45% |
| Sep 30, 2023 | 126.16% |
| Jun 30, 2023 | 85.13% |
| Mar 31, 2023 | -344.54% |
| Dec 31, 2022 | 242.76% |
| Sep 30, 2022 | 1,086.29% |
| Jun 30, 2022 | 99.04% |
| Mar 31, 2022 | -198.08% |
| Dec 31, 2021 | -173.80% |
| Sep 30, 2021 | 3,355.43% |
| Jun 30, 2021 | 98.70% |
| Mar 31, 2021 | -635.20% |
| Dec 31, 2020 | -28.55% |
| Sep 30, 2020 | 207.77% |
| Jun 30, 2020 | 54.61% |
| Mar 31, 2020 | -360.21% |
| Dec 31, 2019 | -464.46% |
| Sep 30, 2019 | -184.33% |
| Jun 30, 2019 | 105.95% |
| Mar 31, 2019 | -292.48% |
| Dec 31, 2018 | 14.20% |
| Sep 30, 2018 | 19.90% |
| Jun 30, 2018 | 52.01% |
| Mar 31, 2018 | -256.16% |
| Dec 31, 2017 | 1.72% |
| Sep 30, 2017 | -278.42% |
| Jun 30, 2017 | 84.36% |
| Mar 31, 2017 | -582.20% |
| Dec 31, 2016 | 60.07% |
| Sep 30, 2016 | 39.40% |
| Jun 30, 2016 | 59.15% |
| Mar 31, 2016 | -69.64% |